声明
CONTENTS
ABSTRACT
摘要
INTRODUCTION
SUBJECTS AND METHODS
Study design
Interventional Procedures
Follow up Clinical outcomes
Statistical Analysis
RESULTS
Patient’s Demographics
Endpoints
DISCUSSIONS
Dual vs Triple Antiplatelet therapy
This study vs other cilostazol-triple antiplatelet therapy trials
Effect of cilostazol on Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Effect of Cilostazol on incidence of periprocedural myonecrosis (PPMN)
Anti-inflammatory effect of pre loading cilostazol by suppression of hsCRP,MPO,TLR4,PAPP-A and PMN
CONCLUSION
Study limitations
References
Literature review
ACKNOWLEDGEMENT